The Food & Drug Administration is seeking public comments on its Center for Veterinary Medicine’s draft guidance entitled “Good Manufacturing Practices for Animal Cells, Tissues, and Cell- and Tissue-Based Products.” That guidance seeks to ensure that the manufacture of such products meeting the definition of new animal drugs complies with the Federal Food, Drug, & Cosmetic Act. The guidance, specifically concerns product identification, safety, strength, purity, and quality. The comment period is open through November 22, 2021.
Opens in a new window
